Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
Background: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF pa...
Autores principales: | Kenji Maruyama, Shinichiro Uchiyama, Tsuyoshi Shiga, Mutsumi Iijima, Kentaro Ishizuka, Takao Hoshino, Kazuo Kitagawa |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Karger Publishers
2017-03-01
|
Colección: | Cerebrovascular Diseases Extra |
Materias: | |
Acceso en línea: | http://www.karger.com/Article/FullText/457808 |
Ejemplares similares
-
Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
por: Tamara Kovačević Preradovic, et al.
Publicado: (2023-01-01) -
Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
por: Chisa Asahina, et al.
Publicado: (2020-10-01) -
One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry
por: C.G. Bahuleyan, et al.
Publicado: (2021-01-01) -
Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study
por: Izzat AlAwwa, et al.
Publicado: (2020-04-01) -
The reliability and validity of a novel Chinese version simplified modified Rankin scale questionnaire (2011)
por: Junliang Yuan, et al.
Publicado: (2020-04-01)